Abstract: Pharmaceutical compositions containing a combination of NPM inhibitor and anti-cancer agent are disclosed. Methods of inhibiting or reducing the growth of cancer cells in a subject, by administering an effective amount of nucleophosmin (NPM) inhibitor and one or more anticancer agents, whereby the symptoms and signs of cancer in the subject are reduced are also provided.
Type:
Grant
Filed:
September 13, 2013
Date of Patent:
March 14, 2017
Assignees:
CHANG GUNG MEMORIAL HOSPITAL, LINKOU & HSIEH, THOMAS